FDNA was incorporated with a mission to give hope to children with rare diseases, and their families.
About 1 in 10 people, or 30 million total, are living with a rare disease in the United States. Globally, it is 350 million people that have one of over 7,000 known rare diseases. The journey to a diagnosis for these children averages seven years from symptoms to diagnosis, in which time they see an average of seven doctors. The emotional and financial burden to families is devastating, negatively impacting the child’s prognosis and quality of life.
Through innovation, FDNA is paving the way for clinicians to diagnose these diseases earlier, for labs to interpret genetic information more accurately and for life science researchers to make new discoveries to help develop rare disease therapies.
We use advanced technologies, including computer vision, deep learning and artificial intelligence to analyze patient symptoms, features and genomic data in a network of thousands of genetics professionals worldwide, delivering scientific insights to improve and accelerate diagnostics and therapeutics, changing the lives of children with rare diseases.
Our story begins in 2011 when our founder sold his technology of tagging facial photos to Facebook. With a desire to have a profound impact on people’s lives, we worked with the healthcare community to identify the “next big thing.” All signs were pointing at genetics as having the potential to make that impact, which solidified after meeting with the families and the children facing these rare diseases first-hand. Using our technology, we are facing rare disease head on with the goal of eliminating the diagnostic odyssey of hundreds of millions of patients around the world.
Learn more at www.FDNA.com